PA
GILD icon

Procyon Advisors’s Gilead Sciences GILD Stock Holding History

Procyon Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16M Sell
17,103
-18,948
-53% -$2.5M 0.09% 182
2026
Q1 		$5.02M Buy
36,051
+7,656
+27% +$1.07M 0.25% 101
2025
Q4 		$3.49M Sell
28,395
-1,809
-6% -$220K 0.17% 122
2025
Q3 		$3.35M Buy
30,204
+3,721
+14% +$423K 0.2% 96
2025
Q2 		$2.94M Buy
26,483
+3,536
+15% +$376K 0.28% 75
2025
Q1 		$2.57M Sell
22,947
-11,367
-33% -$1.17M 0.16% 142
2024
Q4 		$3.17M Sell
34,314
-1,930
-5% -$174K 0.2% 107
2024
Q3 		$3.04M Buy
36,244
+3,214
+10% +$245K 0.21% 110
2024
Q2 		$2.27M Sell
33,030
-1,202
-4% -$80.2K 0.17% 136
2024
Q1 		$2.51M Buy
34,232
+3,955
+13% +$304K 0.19% 124
2023
Q4 		$2.45M Buy
30,277
+1,263
+4% +$98.3K 0.21% 116
2023
Q3 		$2.17M Buy
29,014
+11,688
+67% +$899K 0.22% 112
2023
Q2 		$1.34M Buy
17,326
+7,246
+72% +$578K 0.17% 138
2023
Q1 		$836K Sell
10,080
-5,979
-37% -$495K 0.14% 148
2022
Q4 		$1.38M Sell
16,059
-1,983
-11% -$157K 0.25% 93
2022
Q3 		$1.11M Buy
18,042
+1,087
+6% +$68.5K 0.27% 84
2022
Q2 		$1.05M Sell
16,955
-1,000
-6% -$61.9K 0.23% 98
2022
Q1 		$1.07M Sell
17,955
-4,980
-22% -$318K 0.22% 98
2021
Q4 		$1.67M Buy
22,935
+1,209
+6% +$83.3K 0.36% 65
2021
Q3 		$1.52M Buy
21,726
+8,130
+60% +$571K 0.39% 60
2021
Q2 		$936K Buy
+13,596
New +$908K 0.26% 86
2020
Q4 		– Sell
-3,324
Closed -$210K – 238
2020
Q3 		$210K Sell
3,324
-161
-5% -$11.2K 0.12% 194
2020
Q2 		$268K Buy
3,485
+1,132
+48% +$86.8K 0.14% 142
2020
Q1 		$176K Buy
2,353
+182
+8% +$12.6K 0.12% 169
2019
Q4 		$141K Buy
+2,171
New +$141K 0.09% 217

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Procyon Advisors's GILD Position: Q2 2026 in Review

Procyon Advisors reduced its Gilead Sciences (GILD) stake by 53% in Q2 2026, selling an estimated $2.5M and leaving 17,103 shares worth $2.16M. The position accounts for 0.09% of the portfolio, ranked #182.

Procyon Advisors first reported a position in GILD in Q4 2019 and has held it in 25 quarters since. The position peaked at $5.02M in Q1 2026. 920 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Procyon Advisors held 17,103 shares of Gilead Sciences worth $2.16M as of Q2 2026.
  • Procyon Advisors sold 18,948 Gilead Sciences shares in Q2 2026, an estimated $2.5M.
  • Gilead Sciences made up 0.09% of Procyon Advisors's portfolio in Q2 2026, its #182 holding.
  • Procyon Advisors first reported a position in Gilead Sciences in Q4 2019 and has held it in 25 quarters since.
  • Procyon Advisors's Gilead Sciences position peaked at $5.02M in Q1 2026.
  • 920 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.